Mir-578, miR-573 and miR-122 were selected for validation on an independent set of 19 FFPE familial breast tumors subdivided into 8 BRCA1/2 related breast cancer cases and 11 BRCAX associated breast tumors. The gene discussed is BRCA1; the disease is breast carcinoma.